Benzinga's Top #PreMarket Gainers

Alimera Sciences (NASDAQ: ALIM ) soared 94.12% to $4.95 in the pre-market trading as the company entered labeling discussions with the FDA on ILUVIEN. pSivida (NASDAQ: PSDV ) surged 58.25% to $4.70 in the pre-market session after the company reported FDA labeling discussions for ILUVIEN® for Diabetic Macular Edema